home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

5th Annual The Bioprocessing Summit

 
  May 21, 2013  
     
 
Renaissance Boston Waterfront Hotel, Boston, MA
August 19-23, 2013


Program Titles: 
  • Optimizing Cell Culture Technology
  • Facilities for Manufacturing Biologics
  • Higher-Order Protein Structure
  • Overcoming Formulation Challenges
  • Optimizing Cell Line Development
  • Scaling Up & Down with Optimized Bioreactors
  • Rapid Methods to Assess Quality & Stability of Biologics
  • High-Concentration Protein Formulations
  • Early IND Strategies: Analytical Development
  • Early IND Strategies: Process and Production
 
 
Organized by: Cambridge Healthtech Institute
Invited Speakers:

Keynote Speakers:

  • Thomas Ryll, Ph.D., Director, Cell Culture Development, Biogen Idec, Inc.
  • R. Thomas Warf, Senior Program Manager, Product Process Development Analysis, Influenza and Emerging Diseases Division, Biomedical Advanced Research and Development Authority (BARDA), Office of the Assistant Secretary for Preparedness and Response, U.S. Department of Health and Human Services
  • Palani Palaniappan, Ph.D., Vice President and Head, Biologics CMC, CMC Center, Millennium: The Takeda Oncology Company 
  • Florian M. Wurm, Ph.D., Professor, Chemistry Engineering & Cell Bio Lab, School of Life Sciences, Integrative Bioscience Institute, École Polytechnique Federale De Lausanne (EPFL), and Founder & CSO, ExcellGene SA
  • Ravinder Bhatia, Ph.D., Associate Director, Pharmaceutical Development and Manufacturing Sciences, Janssen Research & Development
  • Jianmei Kochling, Ph.D., Director, Quality Control Technical Services, Genzyme, a Sanofi Company
  • Donna L. Luisi, Ph.D., Senior Principal Scientist, Pharmaceutical Research & Development, Pfizer, Inc. 
  • Thomas Laue, Ph.D., Professor, Biochemistry and Molecular Biology; Director, Biomolecular Interaction Technologies Center (BITC), University of New Hampshire
  • Joanne Beck, Ph.D., Vice President, Process Development, Shire Human Genetic Therapies
To see a full speaker list, visit http://bit.ly/15TG0EW

 

 
Deadline for Abstracts: July 19, 2013
 
Registration: Register Now
E-mail: kwaterman@healthtech.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.